MT 400: Began Phase II trial

Pozen Inc. (POZN), Chapel Hill, N.C. Product: MT 400 Business: Neurological Therapeutic category: Neurotransmission, NSAID Target: 5HT receptors and cyclooxygenase enzymes Description: Combination of ...